The human immunodeficiency virus (HIV) both relies on host cell proteins for its replication, and is opposed by host cell factors, called "restriction factors" with the potential to significantly control viral replication. Our hypothesis is that humans are so susceptible to HIV because our antiviral genes are poorly adapted to this virus, and because HIV-1 has adapted to humans by its own evolution of specific antagonists to these antiviral genes. While some restriction factors are very active against HIV, others work poorly in humans or are polymorphic in the human population with both active and inactive versions. In the APOBEC3 locus of restriction factors, APOBEC3H stands out because some humans make active versions of this protein, while others do not. We will determine how important APOBEC3H is for HIV infection by determining whether or not HIV adapts in humans who encode the most active form of APOBEC3H. We will also study the evolution and function of APOBEC3DE which is a restriction factor that has rapidly evolved since the human-chimpanzee divergence, and we will the exploit the natural infection of African Green Monkeys (AGMs) subspecies with divergent SIVs to understand how polymorphism in the APOBEC3 locus affects the evolution of the lentivirus-host relationship. Finally, we will characterize a restriction factor against HIV, called Viperin, that acts at a late stage of virus replication by a novel mechanism. Overall, the goal of this proposal is to understand how the past evolution and function of these restriction factors impacts HIV replication in humans.
The human immunodeficiency virus (HIV) is the major viral pandemic of the past 25 years. Our study will elucidate the human defenses to HIV in order to understand why humans are so susceptible to this virus, how HIV evades our defenses, and how previous infections of human ancestors may have shaped the evolution of our viral defenses to HIV.
|Refsland, Eric W; Hultquist, Judd F; Luengas, Elizabeth M et al. (2014) Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity. PLoS Genet 10:e1004761|
|Matsen 4th, Frederick A; Small, Christopher T; Soliven, Khanh et al. (2014) A novel Bayesian method for detection of APOBEC3-mediated hypermutation and its application to zoonotic transmission of simian foamy viruses. PLoS Comput Biol 10:e1003493|
|Duggal, Nisha K; Fu, Wenqing; Akey, Joshua M et al. (2013) Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations. Virology 443:329-37|
|Compton, Alex A; Malik, Harmit S; Emerman, Michael (2013) Host gene evolution traces the evolutionary history of ancient primate lentiviruses. Philos Trans R Soc Lond B Biol Sci 368:20120496|
|Etienne, Lucie; Hahn, Beatrice H; Sharp, Paul M et al. (2013) Gene loss and adaptation to hominids underlie the ancient origin of HIV-1. Cell Host Microbe 14:85-92|
|Lim, Efrem S; Fregoso, Oliver I; McCoy, Connor O et al. (2012) The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11:194-204|
|Compton, Alex A; Hirsch, Vanessa M; Emerman, Michael (2012) The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11:91-8|
|Patel, Maulik R; Emerman, Michael; Malik, Harmit S (2011) Paleovirology - Ghosts and gifts of viruses past. Curr Opin Virol 1:304-309|
|Lewinski, Mary K; Yamashita, Masahiro; Emerman, Michael et al. (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2:e60|
|Goh, Wei Chun; Manel, Nicolas; Emerman, Michael (2004) The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest. Virology 318:337-49|
Showing the most recent 10 out of 36 publications